Device Trial Radar · NCT07181590
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
300
Actual
Start
Dec 11, 2025
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Sep 18, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to obtain real-world clinical evidence on the safety and effectiveness of the Volt PFA System in various use cases, with a sub study designed to address additional clinical evidence needs in electrophysiology.
Conditions
- Paroxysmal AF
- Atrial Arrhythmia
- Atrial Fibrillation
- Persistent Atrial Fibrillation
Interventions
Pulsed Field AblationDevice
Pulsed Field Ablation using the Volt PFA System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of subjects experiencing a device and/or procedure-related serious adverse event with onset within 7 days of any ablation procedure that uses Volt AFTime frame: 7 days
- Long-term Effectiveness will be the proportion of subjects with freedom from documented AF/AFL/AT recurrence through 12-months.Time frame: During procedure
- Acute procedural effectiveness is defined as confirmation of entrance block in all targeted pulmonary veinsTime frame: During procedure
Locations
22 sites in 12 countries. Site status is shown where the registry gives one.
Ordensklinikum Linz Elisabethinen
Linz, Austria
AZ Sint Jan
Bruges, Belgium
UZ Brussel
Brussels, Belgium
19 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.